arrow
M

Manu Jokela

Turku University Hospital and Tampere University
H指数:18
被引数:970

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Speech-based digital endpoints track ALS progression and align with standard clinical outcomes: evidence from the VRG50635 trial

基于语音的数字终点追踪肌萎缩侧索硬化症进展并与标准临床结果一致:VRG50635试验的证据

2026-04-140
OA
Characterization of severe COL6-related dystrophy due to the recurrent variant COL6A1 c.930+189C>T

COL6相关严重型肌营养不良的表征:由复发性变异COL6A1 c.930+189C>T引起

Brain
IF11.7
2025-04-030
OA
Anoctamin-5 related muscle disease: clinical and genetic findings in a large European cohort
BRAIN
IF11.7
2023-03-133
OA
NEB mutations disrupt the super-relaxed state of myosin and remodel the muscle metabolic proteome in nemaline myopathy
2022-12-1717
OA
Intron mutations and early transcription termination in Duchenne and Becker muscular dystrophy

杜氏和贝克尔肌营养不良症的内含子突变和早期转录终止

2022-03-0727
OA
Bi-allelic loss-of-function OBSCN variants predispose individuals to severe recurrent rhabdomyolysis
BRAIN
IF11.7
2021-12-249
OA
Missense mutations in small muscle protein X-linked (SMPX) cause distal myopathy with protein inclusions
2021-05-118
OAAI
Genotype-phenotype correlations in recessive titinopathies

隐性titinopathies的基因型-表型相关性

2020-12-0140
OAAI
An unusual ryanodine receptor 1 (RYR1) phenotype Mild calf-predominant myopathy

不寻常的ryanodine受体1 (RYR1) 表型轻度小牛为主的肌病

2019-04-0213
PREAI
Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases
2018-11-0148
OAAI